ORKA (NASDAQ: ORKA) supplement swaps Point72 for SILV Fund in 39.4M resale

Rhea-AI Filing Summary

ORKA filed a prospectus supplement to amend the selling stockholders table: the resale registration still covers 39,425,806 shares of Common Stock, and SILV Fund Ltd. is substituted for Point72 Associates, LLC as a selling stockholder. The supplement cites 49,542,691 shares outstanding as of February 28, 2026 for percentage calculations and shows 531,670 shares listed for SILV Fund Ltd. The supplement does not increase the number of shares registered and repeats the stated market price of $68.87 per share (last reported sale on April 20, 2026).

Key Figures

Registered shares: 39,425,806 shares Last reported sale price: $68.87 Shares outstanding: 49,542,691 shares +1 more

4 metrics

Registered shares 39,425,806 shares resale registration stated in the prospectus supplement

Last reported sale price $68.87 last reported sale price on April 20, 2026

Shares outstanding 49,542,691 shares shares outstanding used for percentage calculations as of February 28, 2026

SILV Fund Ltd. holdings 531,670 shares common stock beneficially owned before the offering (table entry)

Key Terms

prospectus supplement, selling stockholders, resale registration

3 terms

prospectus supplement regulatory

"this prospectus supplement amends and supplements information"

A prospectus supplement is an additional document provided alongside a company's main offering details, offering updated or extra information about a specific financial product being sold. It helps investors understand the latest terms, risks, and details of the investment, similar to how an update or revision clarifies or expands on original instructions, ensuring they have current and complete information before making a decision.

selling stockholders financial

"resale or other disposition by the selling stockholders identified therein"

Selling stockholders are existing owners of a company's shares who are offering some or all of their holdings for sale, often as part of a public offering or secondary transaction. For investors this matters because such sales increase the number of shares available to buy, can signal how confident current owners are about future prospects, and may put short-term pressure on the stock price similar to more tickets being released for a popular event.

resale registration regulatory

"proposed resale or other disposition by the selling stockholders of up to 39,425,806"

Resale registration is the formal filing with securities regulators that allows previously restricted or privately held shares to be sold publicly. Think of it as getting official permission to unlock and list a sealed package of stock so it can be traded openly; that matters to investors because it increases liquidity, can change the number of shares available on the market, and reduces legal risk for sellers, all of which can affect a company’s share price.

Offering Details

resale/secondary

Offering

Offering Type resale/secondary

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 04/21/2026 - 04:23 PM Learn about SEC filing dates

FAQ

What change does the ORKA prospectus supplement make?

It substitutes one selling stockholder for another without increasing the registered shares. The supplement replaces Point72 Associates, LLC with SILV Fund Ltd. in the selling stockholder table while keeping the 39,425,806 shares registration unchanged.

How many shares are covered by the resale registration for ORKA?

The resale registration covers 39,425,806 shares of Common Stock. That aggregate amount is unchanged by this supplement and remains the total number of shares the selling stockholders may resell under the prospectus.

How does the supplement affect dilution or the company’s share count?

It does not change shares outstanding or registered amounts. The document uses 49,542,691 shares outstanding as of February 28, 2026 for percentage calculations; the registered resale amount remains 39,425,806 shares.

What holdings does SILV Fund Ltd. report in this supplement?

SILV Fund Ltd. is listed with 531,670 shares. The line shows 531,670 Common Stock beneficially owned before the offering and the same amount that may be offered by that selling stockholder.

Will ORKA receive proceeds from these resales?

The supplement does not state that the company will receive proceeds. It characterizes the filing as a resale by selling stockholders and specifies that the supplement only amends the selling stockholder table.

Filed Pursuant to Rule 424(b)(7)

Registration No. 333-290715

PROSPECTUS SUPPLEMENT

(To Prospectus dated November 3, 2025)

 

39,425,806 Shares of Common Stock

Offered by the Selling Stockholders

This prospectus supplement (this “prospectus supplement”) amends and supplements information contained or incorporated by reference in the prospectus dated November 3, 2025 (the “prospectus”) relating to the proposed resale or other disposition by the selling stockholders identified therein (the “Selling Stockholders”) of up to 39,425,806 of shares of Common Stock described in the prospectus.

The purpose of this prospectus supplement is solely to supplement and amend the “Selling Stockholders” section commencing on page 11 of the prospectus to reflect in the Selling Stockholder table a transfer from a selling stockholder previously identified in the prospectus to another entity, which, as a result of such transfer, is being substituted as a selling stockholder. This prospectus supplement is not increasing the number of shares being offered under the prospectus, but only reflecting the transfer of shares of Common Stock previously registered.

This prospectus supplement should be read in conjunction with, and is qualified by reference to, the prospectus, except to the extent that information contained herein supersedes the information contained or incorporated by reference in the prospectus. This prospectus supplement may only be delivered or used in connection with the prospectus.

Our Common Stock is traded on The Nasdaq Global Market under the symbol “ORKA.” On April 20, 2026, the last reported sale price for our Common Stock was $68.87 per share.

An investment in our securities involves a high degree of risk. You should carefully consider the information under the heading “Risk Factors” on page 4 of the prospectus and any applicable prospectus supplement.

We are a “smaller reporting company” as defined by Rule 12b-2 of the Exchange Act and are subject to reduced public company reporting requirements.

Neither the SEC nor any state securities commission has approved or disapproved of these securities or determined if this prospectus is truthful or complete. Any representation to the contrary is a criminal offense.

The date of this prospectus is April 21, 2026.

Selling Stockholders

The following information amends and supplements the information that appears under the heading “Selling Stockholders” beginning on page 11 of the prospectus. Capitalized terms used herein but not defined have the meanings ascribed to such terms in the prospectus.

Point72 Associates, LLC, a Selling Stockholder included in the prospectus, transferred shares held by Point72 Associates LLC to SILV Fund Ltd. The table that appears under the heading “Selling Stockholders” in the prospectus is being amended and supplemented to (i) remove Point72 Associates, LLC as a Selling Stockholder and (ii) add SILV Fund Ltd. as a Selling Stockholder. This prospectus supplement does not impact any other Selling Stockholder set forth in the table appearing under the heading “Selling Stockholders” in the prospectus.

The percentages of Common Stock owned after the offering by the Selling Stockholder below are based on 49,542,691 shares of Common Stock outstanding as of February 28, 2026, and assumes the exercise or conversion of any securities exercisable or convertible into Common Stock owned by such Selling Stockholder but not the exercise or conversion of such securities owned by any other Selling Stockholder. All information regarding the Selling Stockholder identified below was provided by such Selling Stockholder.

Common Stock Beneficially Owned Before

Common Stock that May Be Offered Pursuant to

Common Stock Beneficially Owned After the Offering

Stockholder Name

the Offering

Prospectus

Number

Percentage

SILV Fund Ltd. (1)

531,670

531,670

—

—

* Less than 1%

(1) Shares listed under “Common Stock Beneficially Owned Before the Offering” consist of 531,670 shares of Common Stock held by SILV Fund Ltd.  Sirenia Capital Management, LP (“Sirenia”) is the investment manager of SILV Fund, Ltd. and as such has investment and voting power with respect to the securities held by SILV Fund, Ltd.  Sirenia Capital Management GP LLC (“Sirenia GP”) is the general partner of Sirenia. Alex Silverstein is the managing member of Sirenia GP.  Each of SILV Fund, Ltd., Sirenia GP and Mr. Silverstein disclaims beneficial ownership over such securities. The address for the Selling Stockholder is 1674 Meridian Avenue, Suite 320, Miami Beach, FL 33139.